Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Nabla Bio
Nabla Bio is a Cambridge, MA-based company pioneering AI-powered protein design to expand the universe of druggable targets. Founded by experts in protein language modeling, Nabla integrates…
Nabla Bio
Nabla Bio is a Cambridge, MA-based company pioneering AI-powered protein design to expand the universe of druggable targets. Founded by experts in protein language modeling, Nabla integrates…
TL;DR
Headquarters: Cambridge, Massachusetts
Founded: 2020
Core product: AI-driven de novo antibody and protein design platform
Employees (approx.): 22
Notable investors: Khosla Ventures, Zetta Venture Partners, Radical Ventures
Company Overview
Problem Domain
Drug discovery / therapeutic protein and antibody design
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
11000000
Reported $11M priced seed round with participation from Fifty Years and Cantos Ventures.
Series A announced May 14, 2024; participation reported from Zetta Venture Partners, Y Combinator, Khosla Ventures, Fifty Years, Cantos, Boom Capital Ventures.
Investor Signal
“Boom Capital Ventures, Cantos, Fifty Years, Khosla Ventures, Pillar VC, Radical Ventures, Y Combinator, Zetta Venture Partners”
